GlassScriptPhysician profile
Evan M Ross
NPI 1972913069
$3,162.27
in general payments reported to CMS, 2019-2025
24 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,631 · 2020: $482 · 2021: $173 · 2022: $215 · 2023: $361 · 2024: $107 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $912.89 | 2019-2023 | Augment Injectable |
| Arthrosurface Incorporated | $843.31 | 2019 | |
| Treace Medical Concepts, INC. | $584.68 | 2022-2025 | |
| Smith+Nephew, INC. | $103.95 | 2019-2023 | Stravix Pl, Grafix Pl |
| Heron Therapeutics, INC. | $94.49 | 2021 | |
| Organogenesis INC. | $77.47 | 2019-2022 | |
| Abbott Laboratories | $62.70 | 2020 | |
| Horizon Therapeutics Plc | $56.11 | 2019 | |
| Nevro Corp. | $53.86 | 2021-2022 | |
| Crossroads Extremity Systems, LLC | $45.73 | 2019 | |
| Steelhead Surgical INC | $42.87 | 2022 | |
| Anika Therapeutics, INC. | $41.16 | 2024 | Tactoset |
| Medtronic Vascular, INC. | $36.04 | 2019-2020 | |
| Tactile Systems Technology INC | $27.57 | 2019-2020 | |
| Kerecis Limited | $27.16 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $24.33 | 2024 | Qutenza |
| Mimedx Group, INC. | $21.31 | 2025 | |
| Lifenet Health | $20.53 | 2022 | |
| Depuy Synthes Sales INC. | $20.35 | 2023 | Va-Lcp |
| Nalu Medical, INC. | $14.21 | 2021 | |
| Merck Sharp & Dohme LLC | $13.17 | 2019 | |
| Paragon 28, INC. | $13.14 | 2019 | |
| Medtronic, INC. | $12.83 | 2022 | |
| Zyla Life Sciences, INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.